Abstract
As rats develop myocardial infarction (MI) like lesions when injected with large doses of isoproterenol (ISO), this investigation was designed to evaluate the dose-dependent effects of thymoquinone (TQ) on ISO-induced myocardial injury in rats. Adult male rats were divided into negative control, TQ20 (20 mg/kg/day), TQ50 (50 mg/kg/day), ISO positive control, TQ20 + ISO, and TQ50 + ISO groups. In these rats, biochemical, immunobiochemical, and histopathological studies were carried out to evaluate myocardial oxidative stress, inflammation, apoptosis, fibrosis, and autophagy, and the changes in serum cardiac biomarkers. The results showed that TQ pretreatment in ISO-administered rats produced a dose-dependent significant reduction of the myocardial infarct size, markedly reduced the ISO-induced elevation in serum cardiac markers and demonstrated several other important findings related to the cardioprotective efficacy of TQ. First, this study is the first reported research work showing that TQ treatment could increase the myocardial reduced glutathione baseline level, adding an indirect antioxidant effect to its known direct free radical scavenging effect. Second, pretreatment with TQ significantly reduced the markers of myocardial oxidative stress, inflammation, fibrosis, and apoptosis. Third, TQ acted as an autophagy enhancer ameliorating myocardial cell damage and dysfunction. Thus, the morphological and biochemical changes associated with ISO-induced myocardial injury were ameliorated with TQ pretreatment. The extent of this improvement was significantly greater in the TQ50 + ISO group than in the TQ20 + ISO group. The present study, for the first time, demonstrates these dose-dependent effects of TQ in experimentally induced myocardial injury. These findings raise the possibility that TQ may serve as a promising prophylactic cardioprotective therapy for patients who are at risk of developing myocardial injury and against the progression of existent myocardial injury as in cases of MI.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00210-021-02087-1/MediaObjects/210_2021_2087_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00210-021-02087-1/MediaObjects/210_2021_2087_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00210-021-02087-1/MediaObjects/210_2021_2087_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00210-021-02087-1/MediaObjects/210_2021_2087_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00210-021-02087-1/MediaObjects/210_2021_2087_Fig5_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00210-021-02087-1/MediaObjects/210_2021_2087_Fig6_HTML.jpg)
Similar content being viewed by others
References
AbdHalim SAS, AbdGhafar N, Jubri Z, Das S (2018) Induction of myocardial infarction in experimental animals: a review. J Clin Diagn Res 12(11):AE01–AE05
Ahmad A, Husain A, Mujeeb M, Khan SA, Ak N, Siddique NA et al (2013) A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pac J Trop Biomed 3:337–352
Ahmad MF, Ahmad FA, Ashraf SA, Khan SA, Saad HH, Wahab S, Khan MI, et al. (2020) An update knowledge of black seed (Nigella sativa Linn): review of phytochemical constituents and pharmacological properties. https://doi.org/10.1016/j.hermed.2020.100404
Ali BH, Blunden G (2003) Pharmacological and toxicological properties of Nigella sativa. Phytother Res 17(4):299–305
Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, Kajstura J (1998) Apoptosis and myocardial infarction. Basic Res Cardiol 93(Suppl. 3):8–12
Aoyagi T, Matsui T (2011) The cardiomyocyte as a source of cytokines in cardiac injury. J Cell Sci Ther 2012(S5):003. https://doi.org/10.4172/2157-7013.s5-003
Arbeláez LF, Pardo AC, Fantinelli JC, Schinella GR, Mosca SM, Ríos J-L (2018) Cardioprotection and natural polyphenols: an update of clinical and experimental studies. Food Funct 9:6129–6145
Awad AS, Abd Al-Haleem EN, El-Bakly WM, Sherief MA (2016) Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn-Schmiedeberg’s Arch Pharmacol 389(4):381–391
Badary OA, Taha RA, Gamal el-Din AM, Abdel-Wahab MH (2003) Thymoquinone is a potent superoxide anion scavenger. Drug Chem Toxicol 26(2):87–98
Bujak M, Frangogiannis NG (2007) The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74(2):184–195
Caricati-Neto A, Errante PR, Menezes-Rodrigues FS (2019) Recent advances in pharmacological and non-pharmacological strategies of cardioprotection. Int J Mol Sci 20(16):4002
de Haan JJ, Smeets MB, Pasterkamp G, Arslan F (2013) Danger signals in the initiation of the inflammatory response after myocardial infarction. Mediat Inflamm 2013:206039
Farag MM, Ahmed GO, Shehata RR, Kazem AH (2015) Thymoquinone improves the kidney and liver changes induced by chronic cyclosporine A treatment and acute renal ischemia/ reperfusion in rats. J Pharm Pharmacol 67(5):731–739
Galaly SR, Ahmed OM, Mahmoud AM (2014) Thymoquinone and curcumin prevent gentamicin induced liver injury by attenuating oxidative stress, inflammation and apoptosis. J Physiol Pharmacol 65(6):823–832
Gerczuk PZ, Kloner RA (2012) An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol 59(11):969–978
Ghasemi A, Zahediast S (2012) Normality tests for statistical analysis: a guide for non-satisticians. Int J Endocrinol Metab 10(2):486–489
Gökce EC, Kahveci R, Gökce A, Cemil B, Aksoy N, Sargon HF et al (2016) Neuroprotective effects of thymoquinone against spinal cord ischemia-reperfusion injury by attenuation of inflammation, oxidative stress, and apoptosis. J Neurosurg Spine 24:949–959
Grimm D, Elsner D, Schunkert H (1998) Development of heart failure following isoproterenol administration in the rat: role of renin angiotensin system. Cardiovasc Res 37:91–100
Halliwell B (1991) Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 91:14s–22s
Hassan Q, Akhtar M, Ahmed S, Ahmad A, Najmi AK (2017) Nigella sativa protects against isoproterenol-induced myocardial infarction by alleviating oxidative stress, biochemical alterations and histological damage. Asian Pac J Trop Biomed 7(4):294–299
He F, Zuo L (2015) Redox roles of reactive oxygen species in cardiovascular diseases. Int J Med Sci 16(11):27770–27780
Heusch G, Kleinbongard P, Rassaf T (2019) Cardioprotection beyond infarct size reduction. Circ Res 124:679–680
Hasić S, Jadrić R, Kiseljaković E, Mornjaković Z, Winterhalter-Jadrić M (2007) Troponin T and histological characteristics of rat myocardial infarction induced by isoproterenol. Bosn J Basic Med Sci 7(3):212–217
Houghton PJ, Zarka R, de lasHeras B, Hoult JR (1995) Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61(1):33–36
Hrelia S, Bordoni A, Angeloni C, Leoncini E, Biagi P (2004) Nutritional interventions to counteract oxidative stress in cardiac cells. Ital J Biochem 53(4):157–163
Ismail M, Al-Naqeep G, Chan KW (2010) Nigella sativa thymoquinone-rich fraction greately improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radic Biol Med 48(5):664–672
Klionsky DJ, Cucrvo AM, Seglen PO (2007) Methods for monitoring autophagy from yeast to human. Autophagy 3:181–206
Kruk J, Aboul-Enein HY, Kładna A, Bowser JE (2019) Oxidative stress in biological systems and its relation with pathophysiological functions: the effect of physical activity on cellular redox homeostasis. Free Radic Res 53(5):497–521
Leone A (2017) Myocardial infarction: pathological relevance and relationship with coronary risk factors. Curr Pharm Des 23:3205
Lie JT, Pairolero PC, Holley KE, Titus JL (1975) Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs. J Thorac Cardiovasc Surg 69(4):599–605
Liu H, Sun Y, Zhang Y, Yang G, Guo L, Zhao Y et al (2019) Role of thymoquinone in cardiac damage caused by sepsis from BALB/c mice. Inflammation 42(2):516–525
Milei J, Nunez RG, Rapaport M (1978) Pathogenesis of isoproterenol-induced myocardial lesions: its reation to human coagulative myocytolysis. Cardiology 63(3):139–151
Mizushima N, Yoshimori T (2007) How to interpret LC3 immunoblotting. Autophagy 3(6):542–545
Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJL et al (2014) Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 Study. Circulation 129(14):1483–1492
Nascimento BR, Brant LCC, Marino BCA, Passaglia LG, Ribeiro ALP (2019) Implementing myocardial infarction systems of care in low/middle-income countries. Heart 105(1):20–26
Nishikimi M, Appaji N, Yagi K (1972) The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 46(2):849–854
O’Neal WT, Griffin WF, Kent SD, Virag JAI (2012) Cellular pathways of death and survival in acute myocardial. J Clin Exp Cardiol S 6:003
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351–358
Ojha S, Azimullah S, Mohanraj R, Sharma C, Yasin J, Arya DS et al (2015) Thymoquinone protects against myocardial ischemic injury by mitigating oxidative stress and inflammation. Evid Based Complement Alternat Med 2015:143629
Ojha S, Goyal S, Kumari S, Arya DS (2012) Pyruvate attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity. Exp Toxicol Pathol 64(4):393–399
Panda S, Kar A, Banerjee T, Sharma N (2012) Combined effects of quercetin and atenolol in reducing isoproterenol-induced cardiotoxicity in rats: possible mediation through scavenging free radicals. Cardiovasc Toxicol 12:235–242
Pei Z, Hu J, Bai Q, Liu B, Cheng D, Liu H et al (2018) Thymoquinone protects against cardiac damage from doxorubicin-induced heart failure in Sprague-Dawley rats. RSC Adv 8(26):14633–14639
Richardson RJ, Murphy SD (1975) Effect of glutathione depletion on tissue deposition of methylmercury in rats. Toxicol Appl Pharmacol 31(3):505–519
Rona G (1985) Catecholamine cardiotoxicity. J Mol Cell Cardiol 17(4):291–306
Sahak MK, Kabir N, Abbas G, Draman S, Hashim NH, Hasan DS (2016) The role of Nigella and its active constituent in learning and memory. Evid Based Complement Alternat Med 2016:6075679
Saravanan G, Prakash J (2004) Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats. J Ethnopharmacol 94(1):155–158
Shabana A, El-Menyar A, Asim M, Al-Azzeh H, Al Thani H (2013) Cardiovascular benefits of black cumin (Nigella sativa). Cardiovasc Toxicol 13(1):9–21
Shakeri F, Khazaei M, Boskabady MH (2018) Cardiovascular effects of Nigella sativa L and its constituents. Indian J Pharm Sci 80(6):971–983
Somaiya R, Patel H, Handave M (2015) Potential future therapies of myocardial ischemia-reperfusion injury. Indian J Cardio Biol Clin Sci 2:105–112
Sutherland FJ, Hearse DJ (2000) The isolated blood and perfusion fluid perfused heart. Pharmacol Res 41(6):613–627
Tommasino C, Marconi M, Ciarlo L, Matarrese P, Malorni W (2015) Autophagic flux and autophagosome morphogenesis require the participation of sphingolipids. Apoptosis 20(5):645–657
Upaganlawar A, Gandhi H, Balaraman R (2011) Isoproterenol induced myocardial infarction: protective role of natural products. J Pharmacol Toxicol 6(1):1–17
Wang X, Guo Z, Ding Z, Mehta JL (2018) Inflammation, autophagy, and apoptosis after myocardial infarction. J Am Heart Associat 7(9):e008024
Wang Z, Zhang J, Ren T, Dong Z (2016) Targeted metabolomic profiling of cardioprotective effect of Ginkgo biloba L. extract on myocardial ischemia in rats. Phytomedicine 23(6):621–631
World Health Organization (2013) WHO traditional medicine strategy: 2014–2023 World Health Organization: Geneva, Switzerland. https://apps.who.int/iris/handle/10665/92455
World Health Organization, Regional Office for the Western Pacific, Manila (1993) Research guidelines for evaluating the safety and efficacy of herbal medicines. https://apps.who.int/iris/handle/10665/207008
Xiao J, Ke ZP, Shi Y, Zeng Q, Cao Z (2018) The cardioprotective effect of thymoquinone on ischemia-reperfusion injury in isolated rat heart via regulation of apoptosis and autophagy. J Cell Biochem 119(9):7212–7217
Xie M, Morales CR, Lavandero S, Hill JA (2011) Tuning flux: autophagy as a target of heart disease therapy. Curr Opin Cardiol 26(3):216–222
Xiong X, Borrelli F, de Sa FA, Ashfaq T, Feng B (2014) Herbal medicines for cardiovascular diseases. Evid Based Complement Alternat Med 2014:809741
Yimer EM, Tuem KB, Karim A, Ur-Rehman N, Anwar F (2019) Nigella sativa L (black cumin): a promising natural remedyfor a wide range of illnesses. Evid Based Complement Alternat Med 2019:1528635
Zhang J, Knapton A, Lipshultz SE, Weaver JL, Herman EH (2008) Isoproterenol-induced cardiotoxicity in Sprague-Dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury. Toxicol Pathol 36(2):277–278
Zheng Y, Gu S, Li X, Tan J, Liu S, Jiang Y et al (2017) Berbamine postconditioning protects the heart from ischemia/reperfusion injury through modulation of autophagy. Cell Death Dis 8(2):e2577
Zilinyi R, Czompa A, Czegledi A, Gajtko A, Pituk D, Lekli I et al (2018) The cardioprotective effect of metformin in doxorubicin-induced cardiotoxicity: the role of autophagy. Molecules 23(5):E1184
Author information
Authors and Affiliations
Contributions
M.M.F. conceived the idea of this work and made its design. A.A.K. and W.F.E. conducted the experimental work. R.M.R. carried out the histopathological work. M.M.F. analyzed and interpreted the data and wrote the article. All authors read and approved the article before submission. The authors declare that all data were generated in-house and that no paper mill was used.
Corresponding author
Ethics declarations
Ethics approval
The protocol of this study was approved by the Animal Care and Use Committee of the Medical Research Institute, Alexandria University (Alexandria, Egypt). All experimental procedures related to the rats were carried out according to the instructions of the European Directive 2010/63/EU for animal experimentation and the guidelines of the Animal Care and Use Committee, Medical Research Institute, Alexandria University.
Consent to participate
Not applicable.
Consent to publish
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
210_2021_2087_MOESM2_ESM.docx
Supplementary file2 Myocardial infarction area measurement and determination of microtubule-associated protein light chain 3 (LC3) level (DOCX 370 KB)
Rights and permissions
About this article
Cite this article
Farag, M.M., Khalifa, A.A., Elhadidy, W.F. et al. Thymoquinone dose-dependently attenuates myocardial injury induced by isoproterenol in rats via integrated modulations of oxidative stress, inflammation, apoptosis, autophagy, and fibrosis. Naunyn-Schmiedeberg's Arch Pharmacol 394, 1787–1801 (2021). https://doi.org/10.1007/s00210-021-02087-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-021-02087-1